CRS Regulatory Science Fellowship Opportunity Broad Call
LEARN MORE

Improving the Process of Therapeutic Development

Harvard, MIT, and the FDA have partnered to create a center focused on regulatory science, bringing together a range of scientific disciplines that are applied to assess the quality, safety and efficacy of medicinal products and inform regulatory decision-making throughout the lifecycle of a medicine. Working across academia, industry, and government institutions, the Center promotes regulatory science through research and education programs, uniting stakeholders under a common mission: promoting optimal patient health outcomes through biomedical innovation and the availability of safe and effective diagnostics and treatments.

The Regulatory Science Fellowship Program

Our fellowship program is affiliated with the FDA and focuses on training the next generation of regulatory science researchers. Learn more about the research our fellows are conducting or explore opportunities and how to get involved in our program.

News, Events, & Updates

Harvard-MIT CRS and CERGAS Bocconi Transatlantic Roundtable

 

February 13th, 2024 | 9:00 – 10:00 AM EST (15:00 – 16:00 CET)

 

Register Here!

 

 

Innovators in Therapeutics Speaker Series

 

Jeffrey Jonas, Director, Sage Therapeutics and Chairman of the Board, Noema Pharma

 

February 27th, 2024 | 12pm – 1:00 PM ET

 

Register Here!

 

 

Regulatory Science Forum

 

Kenneth Getz, Executive Director and Professor, Tufts Center for the Study of Drug Development

 

March 5th, 2024 | 12pm – 1:00 PM ET

 

Register Here!